Inventor
OGITANI YUSUKE
JP12 patents
Patents
12 patentsUS10195288B2Feb 5, 2019
Antibody-drug conjugate
DAIICHI SANKYO CO LTD43 citations98
US9808537B2Nov 7, 2017
Antibody-drug conjugate
DAIICHI SANKYO CO LTD44 citations98
US10729782B2Aug 4, 2020
Antibody-drug conjugate produced by binding through linker having hydrophilic structure
DAIICHI SANKYO CO LTD18 citations94
US10155821B2Dec 18, 2018
Anti-HER2 antibody-drug conjugate
DAIICHI SANKYO CO LTD17 citations94
US9872924B2Jan 23, 2018
Antibody-drug conjugate produced by binding through linker having hydrophilic structure
DAIICHI SANKYO CO LTD36 citations94
US10973924B2Apr 13, 2021
Antibody-drug conjugate
DAIICHI SANKYO CO LTD9 citations86
US11795236B2Oct 24, 2023
Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate
DAIICHI SANKYO CO LTD6 citations85
US11633493B2Apr 25, 2023
Antibody-drug conjugate
DAIICHI SANKYO CO LTD1 citations73
US11584800B2Feb 21, 2023
Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate
DAIICHI SANKYO CO LTD2 citations73
US12186310B2Jan 7, 2025
Antibody-drug conjugate
DAIICHI SANKYO CO LTD0 citations62
US12497465B2Dec 16, 2025
Combination of antibody-drug conjugate and tubulin inhibitor
DAIICHI SANKYO CO LTD0 citations54
US11185594B2Nov 30, 2021
(Anti-HER2 antibody)-drug conjugate
DAIICHI SANKYO CO LTD0 citations52